Literature DB >> 17660122

CyberKnife robotic arm stereotactic radiosurgery.

Mehrdad Sarfaraz1.   

Abstract

Mesh：

Year:  2007        PMID： 17660122     DOI： 10.1016/j.jacr.2007.05.003

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN： 1546-1440            Impact factor:   5.532


× No keyword cloud information.
  6 in total

1.  Multimodality treatment of recurrent pancreatic cancer: Mith or reality?

Authors:  Cosimo Sperti; Lucia Moletta; Stefano Merigliano
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

2.  Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.

Authors:  Jenny Que; Hsing-Tao Kuo; Li-Ching Lin; Kuei-Li Lin; Chia-Hui Lin; Yu-Wei Lin; Ching-Chieh Yang
Journal:  BMC Cancer       Date:  2016-07-12       Impact factor: 4.430

3.  Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity.

Authors:  Ping Liang; Cheng Huang; Shi-Xiong Liang; Ye-Fei Li; Shang-Xiao Huang; Zu-Ping Lian; Jian-Min Liu; Yang Tang; Hai-Jie Lu
Journal:  Onco Targets Ther       Date:  2016-11-18       Impact factor: 4.147

4.  Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis.

Authors:  Byung Ock Choi; Ihl Bohng Choi; Hong Seok Jang; Young Nam Kang; Ji Sun Jang; Si Hyun Bae; Seung Kew Yoon; Gyu Young Chai; Ki Mun Kang
Journal:  BMC Cancer       Date:  2008-11-27       Impact factor: 4.430

5.  The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities.

Authors:  Jenny Y Que; Li-Ching Lin; Kuei-Li Lin; Chia-Hui Lin; Yu-Wei Lin; Ching-Chieh Yang
Journal:  Radiat Oncol       Date:  2014-05-28       Impact factor: 3.481

Review 6.  Practical considerations for prostate hypofractionation in the developing world.

Authors:  Michael Yan; Andre G Gouveia; Fabio L Cury; Nikitha Moideen; Vanessa F Bratti; Horacio Patrocinio; Alejandro Berlin; Lucas C Mendez; Fabio Y Moraes
Journal:  Nat Rev Urol       Date:  2021-08-13       Impact factor: 14.432
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.